iBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate
15 juil. 2021 17h10 HE
|
iBio, Inc.
BRYAN, Texas, July 15, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced that...
iBio Establishes Oncology Drug Discovery Pipeline with Three New Antibody Programs
08 juil. 2021 16h15 HE
|
iBio, Inc.
BRYAN, Texas, July 08, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, has taken another major step...
iBio Further Strengthens Board with Appointment of Veteran Biopharmaceutical Executive, Eef Schimmelpennink
09 juin 2021 16h30 HE
|
iBio, Inc.
BRYAN, Texas, June 09, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today the...
iBio to Present at the UBS Global Healthcare Virtual Conference
19 mai 2021 16h30 HE
|
iBio, Inc.
BRYAN, Texas, May 19, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that...
iBio Reports Fiscal Third Quarter 2021 Financial Results and Provides Corporate Update
17 mai 2021 07h00 HE
|
iBio, Inc.
BRYAN, Texas., May 17, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced its...
iBio to Report Fiscal 2021 Third Quarter Financial Results and Provide Corporate Update on Monday, May 17, 2021
10 mai 2021 08h15 HE
|
iBio, Inc.
BRYAN, Texas, May 10, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that it will...
iBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program
06 mai 2021 16h15 HE
|
iBio, Inc.
BRYAN, Texas, May 06, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today provided an update on...
iBio and Fraunhofer USA Conclude Litigation and Enter License Agreement
04 mai 2021 17h00 HE
|
iBio, Inc.
BRYAN, Texas, May 04, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that...
iBio to Participate in the 33rd Annual Roth Conference
09 mars 2021 16h30 HE
|
iBio, Inc.
BRYAN, Texas, March 09, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced that it...
iBio Reports Fiscal Second Quarter 2021 Financial Results and Provides Corporate Update
16 févr. 2021 16h05 HE
|
iBio, Inc.
BRYAN, Tx., Feb. 16, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced its financial...